New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports
Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia
Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer
Study Finds No Link Between Pill And Breast Cancer Risk
Vasectomy Doesn’t Increase Prostate Cancer Risk
Drug Slows Tumor Growth In Metastatic Kidney Cancer
STI-571 Effects Are Lasting Against GI Stromal Tumors
Monoclonal Antibody Improves AML Response To Therapy
Protocols Approved During the Month of June 2002
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters - More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data in ACS guideline support greater use of noninvasive tests to ease system strain, save lives - David Gius assumes role of director of the University of Cincinnati Cancer Center
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
